{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:02:04Z","timestamp":1757311324238,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["LE 940\/7-1"],"award-info":[{"award-number":["LE 940\/7-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1116"],"award-info":[{"award-number":["SFB1116"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009400","name":"Medizinische Fakult\u00e4t, Heinrich-Heine-Universit\u00e4t D\u00fcsseldorf","doi-asserted-by":"publisher","award":["Forschungskommission 16-2014"],"award-info":[{"award-number":["Forschungskommission 16-2014"]}],"id":[{"id":"10.13039\/501100009400","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009400","name":"Medizinische Fakult\u00e4t, Heinrich-Heine-Universit\u00e4t D\u00fcsseldorf","doi-asserted-by":"crossref","award":["Forschungskommission 46-2016"],"award-info":[{"award-number":["Forschungskommission 46-2016"]}],"id":[{"id":"10.13039\/501100009400","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00228-020-02915-y","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T01:02:31Z","timestamp":1591318951000},"page":"1245-1251","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A novel mechanism of ACE inhibition\u2013associated enhanced platelet reactivity: disproof of the ARB-MI paradox?"],"prefix":"10.1007","volume":"76","author":[{"given":"Carolin","family":"Helten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Mourikis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Dannenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9","family":"M\u2019Pembele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kajetan","family":"Trojovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysel","family":"Ayhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Kohlmorgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Grandoch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bodo","family":"Levkau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verena","family":"Veulemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Petzold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Hohlfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malte","family":"Kelm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Zeus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5406-3937","authenticated-orcid":false,"given":"Amin","family":"Polzin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,5]]},"reference":[{"key":"2915_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2105\/AJPH.47.4_Pt_2.4","volume":"47","author":"TR Dawber","year":"1957","unstructured":"Dawber TR, Moore FE, Mann GV (1957) Coronary heart disease in the Framingham study. Am J Public Health Nations Health. 47:4\u201324","journal-title":"Am J Public Health Nations Health."},{"key":"2915_CR2","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.2105\/AJPH.55.9.1355","volume":"55","author":"WB Kannel","year":"1965","unstructured":"Kannel WB, Dawber TR, Cohen ME, McNamara PM (1965) Vascular disease of the brain--epidemiologic aspects: the Farmingham study. Am J Public Health Nations Health. 55:1355\u20131366","journal-title":"Am J Public Health Nations Health."},{"key":"2915_CR3","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","volume":"275","author":"D Levy","year":"1996","unstructured":"Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK (1996) The progression from hypertension to congestive heart failure. JAMA. 275:1557\u20131562","journal-title":"JAMA."},{"key":"2915_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0140-6736(99)07051-8","volume":"355","author":"S Port","year":"2000","unstructured":"Port S, Demer L, Jennrich R, Walter D, Garfinkel A (2000) Systolic blood pressure and mortality. Lancet. 355:175\u2013180","journal-title":"Lancet."},{"key":"2915_CR5","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1161\/CIRCULATIONAHA.116.025950","volume":"135","author":"FH Messerli","year":"2017","unstructured":"Messerli FH, Bangalore S (2017) Angiotensin receptor blockers reduce cardiovascular events, including the risk of myocardial infarction. Circulation. 135:2085\u20132087","journal-title":"Circulation."},{"key":"2915_CR6","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1093\/eurheartj\/ehs075","volume":"33","author":"LC van Vark","year":"2012","unstructured":"van Vark LC, Bertrand M, Akkerhuis KM, Brugts JJ, Fox K, Mourad JJ, Boersma E (2012) Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients. Eur Heart J. 33:2088\u20132097","journal-title":"Eur Heart J."},{"key":"2915_CR7","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1097\/HJH.0b013e328306ebe2","volume":"26","author":"G Reboldi","year":"2008","unstructured":"Reboldi G, Angeli F, Cavallini C, Gentile G, Mancia G, Verdecchia P (2008) Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis. J Hypertens. 26:1282\u20131289","journal-title":"J Hypertens."},{"key":"2915_CR8","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","volume":"387","author":"D Ettehad","year":"2016","unstructured":"Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, Chalmers J, Rodgers A, Rahimi K (2016) Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 387:957\u2013967","journal-title":"Lancet."},{"key":"2915_CR9","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.jacc.2018.01.058","volume":"71","author":"FH Messerli","year":"2018","unstructured":"Messerli FH, Bangalore S, Bavishi C, Rimoldi SF (2018) Angiotensin-converting enzyme inhibitors in hypertension: to use or not to use? J Am Coll Cardiol. 71:1474\u20131482","journal-title":"J Am Coll Cardiol."},{"key":"2915_CR10","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I, Group ESCSD (2018) 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 39:3021\u20133104","journal-title":"Eur Heart J."},{"key":"2915_CR11","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1056\/NEJMoa032292","volume":"349","author":"MA Pfeffer","year":"2003","unstructured":"Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Kober L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM, Valsartan in Acute Myocardial Infarction Trial I (2003) Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 349:1893\u20131906","journal-title":"N Engl J Med"},{"key":"2915_CR12","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1161\/CIRCULATIONAHA.105.594986","volume":"114","author":"MH Strauss","year":"2006","unstructured":"Strauss MH, Hall AS (2006) Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradox. Circulation. 114:838\u2013854","journal-title":"Circulation."},{"key":"2915_CR13","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1016\/j.jacc.2013.07.101","volume":"62","author":"US Tantry","year":"2013","unstructured":"Tantry US, Bonello L, Aradi D, Price MJ, Jeong YH, Angiolillo DJ, Stone GW, Curzen N, Geisler T, Ten Berg J, Kirtane A, Siller-Matula J, Mahla E, Becker RC, Bhatt DL, Waksman R, Rao SV, Alexopoulos D, Marcucci R, Reny JL, Trenk D, Sibbing D, Gurbel PA, Working Group on On-Treatment Platelet R (2013) Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J Am Coll Cardiol 62:2261\u20132273","journal-title":"J Am Coll Cardiol"},{"key":"2915_CR14","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1159\/000452269","volume":"136","author":"S Antoniak","year":"2017","unstructured":"Antoniak S, Cardenas JC, Buczek LJ, Church FC, Mackman N, Pawlinski R (2017) Protease-activated receptor 1 contributes to angiotensin ii-induced cardiovascular remodeling and inflammation. Cardiology. 136:258\u2013268","journal-title":"Cardiology."},{"key":"2915_CR15","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1160\/th14-03-0243","volume":"112","author":"S Antoniak","year":"2014","unstructured":"Antoniak S, Sparkenbaugh E, Pawlinski R (2014) Tissue factor, protease activated receptors and pathologic heart remodelling. Thromb Haemost. 112:893\u2013900","journal-title":"Thromb Haemost."},{"key":"2915_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejphar.2015.01.028","volume":"751","author":"A Polzin","year":"2015","unstructured":"Polzin A, Schleicher M, Seidel H, Scharf RE, Merx MW, Kelm M, Zeus T (2015) High on-treatment platelet reactivity in transcatheter aortic valve implantation patients. Eur J Pharmacol. 751:24\u201327","journal-title":"Eur J Pharmacol."},{"key":"2915_CR17","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3109\/09537104.2015.1096335","volume":"27","author":"A Polzin","year":"2016","unstructured":"Polzin A, Dannenberg L, Sophia Popp V, Kelm M, Zeus T (2016) Antiplatelet effects of clopidogrel and aspirin after interventional patent foramen ovale\/ atrium septum defect closure. Platelets. 27:317\u2013321","journal-title":"Platelets."},{"key":"2915_CR18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.vph.2015.07.015","volume":"77","author":"A Polzin","year":"2016","unstructured":"Polzin A, Afzal S, Balzer J, Rassaf T, Kelm M, Zeus T (2016) Platelet reactivity in MitraClip patients. Vascul Pharmacol. 77:54\u201359","journal-title":"Vascul Pharmacol."},{"key":"2915_CR19","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/jth.13211","volume":"14","author":"A Polzin","year":"2016","unstructured":"Polzin A, Dannenberg L, Sansone R, Levkau B, Kelm M, Hohlfeld T, Zeus T (2016) Antiplatelet effects of aspirin in chronic kidney disease patients. J Thromb Haemost. 14:375\u2013380","journal-title":"J Thromb Haemost."},{"key":"2915_CR20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ijcard.2017.02.122","volume":"236","author":"A Achilles","year":"2017","unstructured":"Achilles A, Mohring A, Dannenberg L, Piayda K, Levkau B, Hohlfeld T, Zeus T, Kelm M, Polzin A (2017) Analgesic medication with dipyrone in patients with coronary artery disease: relation to MACCE. International journal of cardiology. 236:76\u201381","journal-title":"International journal of cardiology."},{"key":"2915_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.vph.2016.06.003","volume":"87","author":"L Dannenberg","year":"2016","unstructured":"Dannenberg L, Erschoff V, Bonner F, Gliem M, Jander S, Levkau B, Kelm M, Hohlfeld T, Zeus T, Polzin A (2016) Dipyrone comedication in aspirin treated stroke patients impairs outcome. Vascul Pharmacol. 87:66\u201369","journal-title":"Vascul Pharmacol."},{"key":"2915_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1160\/TH14-11-0922","volume":"114","author":"A Polzin","year":"2015","unstructured":"Polzin A, Richter S, Schror K, Rassaf T, Merx MW, Kelm M, Hohlfeld T, Zeus T (2015) Prevention of dipyrone (metamizole) induced inhibition of aspirin antiplatelet effects. Thromb Haemost. 114:87\u201395","journal-title":"Thromb Haemost."},{"key":"2915_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/bmj.39430.529549.BE","volume":"336","author":"G Krasopoulos","year":"2008","unstructured":"Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR (2008) Aspirin \u201cresistance\u201d and risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ. 336:195\u2013198","journal-title":"BMJ."},{"key":"2915_CR24","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/194927b0","volume":"194","author":"GV Born","year":"1962","unstructured":"Born GV (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 194:927\u2013929","journal-title":"Nature."},{"key":"2915_CR25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000073575","volume":"32","author":"HC Hemker","year":"2002","unstructured":"Hemker HC, Giesen P, AlDieri R, Regnault V, de Smed E, Wagenvoord R, Lecompte T, Beguin S (2002) The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb. 32:249\u2013253","journal-title":"Pathophysiol Haemost Thromb."},{"key":"2915_CR26","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1111\/j.1538-7836.2007.02719.x","volume":"5","author":"SN Tchaikovski","year":"2007","unstructured":"Tchaikovski SN, Vlijmen BJMVAN, Rosing J, Tans G (2007) Development of a calibrated automated thrombography based thrombin generation test in mouse plasma. J Thromb Haemost 5:2079\u20132086","journal-title":"J Thromb Haemost"},{"key":"2915_CR27","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/ncpneph0575","volume":"3","author":"AS Bomback","year":"2007","unstructured":"Bomback AS, Klemmer PJ (2007) The incidence and implications of aldosterone breakthrough. Nat Clin Pract Nephrol. 3:486\u2013492","journal-title":"Nat Clin Pract Nephrol."},{"key":"2915_CR28","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.hfc.2014.07.002","volume":"10","author":"BN Reed","year":"2014","unstructured":"Reed BN, Street SE, Jensen BC (2014) Time and technology will tell: the pathophysiologic basis of neurohormonal modulation in heart failure. Heart Fail Clin. 10:543\u2013557","journal-title":"Heart Fail Clin."}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-020-02915-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-020-02915-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-020-02915-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T23:17:20Z","timestamp":1622848640000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-020-02915-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,5]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["2915"],"URL":"https:\/\/doi.org\/10.1007\/s00228-020-02915-y","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"type":"print","value":"0031-6970"},{"type":"electronic","value":"1432-1041"}],"subject":[],"published":{"date-parts":[[2020,6,5]]},"assertion":[{"value":"28 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The study conformed to the Declaration of Helsinki and was accepted by the University of D\u00fcsseldorf Ethics Committee (n\u00b0 5505R).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics committee approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}